• About
  • Advertise
  • Privacy & Policy
  • Contact
HK Businesswire
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World
    Musim Mas and Osiris Technology Advance Digital Biodiversity Monitoring

    Musim Mas and Osiris Technology Advance Digital Biodiversity Monitoring

    Jumpshot 3×3 Academy Sweeps Under-14 Boys’ Podium at ActiveSG Cup, as 14 Young Players Join National Development Pathways

    One in 3 Recipients Struggle to Pay for Essentials Due to ‘Friction Tax’ in Fragmented Global Payment Rails

    Thunes and PayerMax Deepen Strategic Collaboration to Enhance Global Payout Capabilities

    Getac’s New MX60 and MX60W Bring Mission-Critical Computing to Operators at the Tactical Edge

    Getac’s New MX60 and MX60W Bring Mission-Critical Computing to Operators at the Tactical Edge

    Brighton College (Singapore) Announces Founding Sixth Form Pupil Leaders to Mentor and Inspire Younger Pupils

    Brighton College (Singapore) Announces Founding Sixth Form Pupil Leaders to Mentor and Inspire Younger Pupils

    First Patients Dosed in Phase 2 SIRIUS COPD Study of HBM9378/WIN378, a Fully Human Ultra Long-Acting Anti-TSLP Antibody

    Harbour BioMed’s Partner Spruce Biosciences Separates CRHX-101 Program into Adrenyx Biosciences, Advancing Development of Harbour BioMed-Originated Antibody through a Standalone Company

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    Cathay Cargo Launches AI Compliance Tool to Streamline Global Trade Operations

    PCCW Global and Druid Technology Partner on Belt and Road IoT Connectivity

    Alipay Launches Domestic Full-Stack Intelligent Agent Platform in Hangzhou

    HKT Posts 4% Profit Rise Amid Steady Local Recovery and AI-Driven Demand

    Alipay Launches AI-Powered Version ‘Abao’ to Streamline Services

    Xiaohongshu Prepares Confidential Hong Kong IPO Filing

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World
    Musim Mas and Osiris Technology Advance Digital Biodiversity Monitoring

    Musim Mas and Osiris Technology Advance Digital Biodiversity Monitoring

    Jumpshot 3×3 Academy Sweeps Under-14 Boys’ Podium at ActiveSG Cup, as 14 Young Players Join National Development Pathways

    One in 3 Recipients Struggle to Pay for Essentials Due to ‘Friction Tax’ in Fragmented Global Payment Rails

    Thunes and PayerMax Deepen Strategic Collaboration to Enhance Global Payout Capabilities

    Getac’s New MX60 and MX60W Bring Mission-Critical Computing to Operators at the Tactical Edge

    Getac’s New MX60 and MX60W Bring Mission-Critical Computing to Operators at the Tactical Edge

    Brighton College (Singapore) Announces Founding Sixth Form Pupil Leaders to Mentor and Inspire Younger Pupils

    Brighton College (Singapore) Announces Founding Sixth Form Pupil Leaders to Mentor and Inspire Younger Pupils

    First Patients Dosed in Phase 2 SIRIUS COPD Study of HBM9378/WIN378, a Fully Human Ultra Long-Acting Anti-TSLP Antibody

    Harbour BioMed’s Partner Spruce Biosciences Separates CRHX-101 Program into Adrenyx Biosciences, Advancing Development of Harbour BioMed-Originated Antibody through a Standalone Company

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    Cathay Cargo Launches AI Compliance Tool to Streamline Global Trade Operations

    PCCW Global and Druid Technology Partner on Belt and Road IoT Connectivity

    Alipay Launches Domestic Full-Stack Intelligent Agent Platform in Hangzhou

    HKT Posts 4% Profit Rise Amid Steady Local Recovery and AI-Driven Demand

    Alipay Launches AI-Powered Version ‘Abao’ to Streamline Services

    Xiaohongshu Prepares Confidential Hong Kong IPO Filing

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
HK Businesswire
No Result
View All Result
Home News PR Newswire

Kyowa Kirin Announces Abstract Presentation at the European Academy of Dermatology and Venereology (EADV) Congress

PR Newswire by PR Newswire
29 July 2025
in PR Newswire
0
Putting Patients First, Co-Creating a Bright Future for Human Health: Henlius Releases 2024 ESG Report
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

PRINCETON, N.J. and TOKYO, July 29, 2025 /PRNewswire/ — Kyowa Kirin Co., Ltd. (TSE: 4151) today announced that results of the Phase 3 ROCKET IGNITE trial of rocatinlimab, an investigational therapy targeting the OX40 receptor (OX40R) in patients with moderate-to-severe atopic dermatitis (AD), will be presented at the European Academy of Dermatology and Venereology (EADV) 2025 Annual Meeting to be held in Paris, France from September 17-20, 2025.

AD, a chronic, heterogeneous, inflammatory disease characterized by skin redness, pruritus, and pain, is driven by skin barrier disruption and T-cell-dependent inflammatory pathways. Expansion of OX40R+ pathogenic T cells leads to T-cell imbalance, a root cause of inflammatory diseases including AD.

Title: Efficacy & Safety of OX-40 Receptor Targeting with Rocatinlimab in Moderate-to-Severe Atopic Dermatitis: Results from the Phase 3 ROCKET-IGNITE Trial

Presenter: Emma Guttman-Yassky, MD, PhD

Date: Friday, September 19th
Time: 4:40 – 4:50 pm CEST
Session: FC 08 Atopic Dermatitis
Location: Paris Convention Centre, Pavillon 7.3, Room W05-W06

About the ROCKET Phase 3 Program
ROCKET is a comprehensive, global Phase 3 clinical trial program comprised of eight studies intended to establish the safety and efficacy profile of rocatinlimab in adults and adolescents with moderate to severe atopic dermatitis (AD) as well as multiple dosing regimens.

About Moderate to Severe Atopic Dermatitis
Atopic dermatitis, the most common form of eczema, is a chronic inflammatory disease that causes excessively dry, itchy skin that can be painful. People with moderate to severe atopic dermatitis experience chronic symptoms, intensified by unpredictable flare-ups that can be painful and disruptive to everyday life. More than half of these patients report severe itching, leading to repeated scratching which can cause the skin to thicken and become vulnerable to infection. Atopic dermatitis (all severities) affects 15-20% of children and up to 10% of adults. T-cell imbalance is a root cause of atopic dermatitis, contributing to clinical manifestations including the disease’s recurring, unpredictable symptoms.

About Rocatinlimab
Rocatinlimab is an anti-OX40 human monoclonal antibody being investigated for the treatment of moderate to severe atopic dermatitis. Rocatinlimab has the potential to be the first and only T-cell rebalancing therapy that inhibits and reduces pathogenic T cells by targeting the OX40 receptor. OX40 is a co-stimulatory receptor responsible for driving systemic and local inflammatory responses in atopic dermatitis and other conditions. It has been reported that effector T cells expressing OX40 are present in the lesions of patients with atopic dermatitis and are critical in the disease pathophysiology.

Rocatinlimab is also being studied for prurigo nodularis, moderate to severe uncontrolled asthma and potentially other conditions where T-cell imbalance is a root cause of inflammation. The initial antibody was discovered in collaboration between Kyowa Kirin and La Jolla Institute for Immunology.

Rocatinlimab is currently under clinical investigation, and its safety and efficacy have not been evaluated by the U.S. FDA or any other regulatory authority.

About Kyowa Kirin
Kyowa Kirin aims to discover and deliver novel medicines and treatments with life-changing value. As a Japan-based Global Specialty Pharmaceutical Company, we have invested in drug discovery and biotechnology innovation for more than 70 years and are currently working to engineer the next generation of antibodies and cell and gene therapies with the potential to help patients with high unmet medical needs, such as bone & mineral, intractable hematological diseases/hemato oncology, and rare diseases. A shared commitment to our values, to sustainable growth, and to making people smile unites us across the globe. You can learn more about the business of Kyowa Kirin at: https://www.kyowakirin.com/.   

Amgen and Kyowa Kirin Collaboration
On June 1, 2021, Kyowa Kirin and Amgen entered into an agreement to jointly develop and commercialize rocatinlimab. Under the terms of the agreement, Amgen will lead the development, manufacturing, and commercialization for KHK4083/AMG 451 for all markets globally, except Japan, where Kyowa Kirin will retain all rights. If approved, the companies will co-promote the asset in the United States and Kyowa Kirin has opt-in rights to co-promote in certain other markets including Europe and Asia.

CONTACT:

Kyowa Kirin
Hiroki Nakamura: Japan
Corporate Communications Department
media@kyowakirin.com

Subrenie Thomas-Smith: North America
Sr. Director, R&D Patient Engagement & Communications
subrenie.thomas-smith.8c@kyowakirin.com

Tags: prnewswire
PR Newswire

PR Newswire

PR Newswire is the industry’s leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.

Read More

LX Pantos Americas Marks New Chapter in Midwest Growth with Chicago Office Opening

LX Pantos Americas Marks New Chapter in Midwest Growth with Chicago Office Opening

18 November 2026
GFTN and LHoFT Partner to Launch the Future of Wealth Forum for AI, New Asset Classes and the Next Generation

GFTN and LHoFT Partner to Launch the Future of Wealth Forum for AI, New Asset Classes and the Next Generation

18 November 2026
  • Trending
  • Comments
  • Latest

World Winter Sports Expo 2026 Opens, Charting a New Decade for Ice and Snow and Outdoor Industries

17 October 2026
Newgen reports Revenue of ₹357 crores in Q1 FY’27, up 11% Q1 YoY; Profit After Tax at ₹63 crores, up 26% Q1 YoY

Newgen Software and the Asian Institute of Digital Finance Forge Strategic Partnership to Shape the Future of Enterprise AI

10 November 2026

HK five-year plan offers UK long-term prospects: CE

10 November 2026

Watch the universe emerge from the dark ages, with Lumina

26 October 2026
Musim Mas and Osiris Technology Advance Digital Biodiversity Monitoring

Musim Mas and Osiris Technology Advance Digital Biodiversity Monitoring

18 November 2026

Jumpshot 3×3 Academy Sweeps Under-14 Boys’ Podium at ActiveSG Cup, as 14 Young Players Join National Development Pathways

18 November 2026
One in 3 Recipients Struggle to Pay for Essentials Due to ‘Friction Tax’ in Fragmented Global Payment Rails

Thunes and PayerMax Deepen Strategic Collaboration to Enhance Global Payout Capabilities

18 November 2026
Getac’s New MX60 and MX60W Bring Mission-Critical Computing to Operators at the Tactical Edge

Getac’s New MX60 and MX60W Bring Mission-Critical Computing to Operators at the Tactical Edge

18 November 2026

Recent News

Musim Mas and Osiris Technology Advance Digital Biodiversity Monitoring

Musim Mas and Osiris Technology Advance Digital Biodiversity Monitoring

18 November 2026

Jumpshot 3×3 Academy Sweeps Under-14 Boys’ Podium at ActiveSG Cup, as 14 Young Players Join National Development Pathways

18 November 2026
One in 3 Recipients Struggle to Pay for Essentials Due to ‘Friction Tax’ in Fragmented Global Payment Rails

Thunes and PayerMax Deepen Strategic Collaboration to Enhance Global Payout Capabilities

18 November 2026
Getac’s New MX60 and MX60W Bring Mission-Critical Computing to Operators at the Tactical Edge

Getac’s New MX60 and MX60W Bring Mission-Critical Computing to Operators at the Tactical Edge

18 November 2026
HK Businesswire

Stay ahead with the latest insights on Hong Kong’s economy, finance, and investments. From market trends to policy updates, we bring you in-depth analysis and expert opinions.

📩 Subscribe to our newsletter for exclusive updates.
📍 Follow us on social media for real-time news.
📧 Contact us: info@hongkong-invest.com

Follow Us

  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2025 by HKBusinesswire.com

No Result
View All Result

© 2025 by HKBusinesswire.com